Helmut Schiffl

Suggest Changes

Writes About:

Learn More
BACKGROUND The study was designed to investigate the safety and feasibility of gadopentetate dimeglumine, a gadolinium-based contrast medium, as an alternative angiographic contrast agent in patients(More)